Skip to content
OpenCapital
Get started

Ginkgo Bioworks DNA Accrued Progress Collections and Price Adjustments

Accrued Progress Collections and Price Adjustments at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
——
Charles River Laboratories logo
Charles River LaboratoriesCRL
——
Regenxbio logo
RegenxbioRGNX
——
ClearPoint Neuro logo
ClearPoint NeuroCLPT
——
Guardant Health logo
Guardant HealthGH
——

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's accrued progress collections and price adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's accrued progress collections and price adjustments?
Ginkgo Bioworks (DNA) reported accrued progress collections and price adjustments of $77.9M in Q1 2026.
How has Ginkgo Bioworks's accrued progress collections and price adjustments changed year-over-year?
Ginkgo Bioworks's accrued progress collections and price adjustments decreased by 3.1% year-over-year, from $80.38M to $77.9M.
What is the long-term trend for Ginkgo Bioworks's accrued progress collections and price adjustments?
Over 3 years (2022 to 2025), Ginkgo Bioworks's accrued progress collections and price adjustments has grown at a -24.5% compound annual growth rate (CAGR), from $174.77M to $75.18M.